| Literature DB >> 29985678 |
Masoomeh Mohebbi1, Masoud Mirghorbani1, Ali Banafshe Afshan1, Mohsen Towfighi1.
Abstract
Ocular lichen planus (LP) is a rare disease which has been increasingly reported in the literature in the last two decades involving conjunctiva, cornea, and lacrimal drainage system. Most reported cases of ocular LP are cicatricial conjunctivitis with subepithelial fibrosis, fornix shortening, and symblepharon formation. It is not clear whether corneal involvement is a primary event or secondary to these changes. Topical cyclosporine and corticosteroid can be considered as first-line therapy in ocular surface involvement, while treatment regimen in more aggravated disease should be boosted with systemic immunosuppressives. After resolving acute inflammation, the patient should be treated with long-term maintenance therapy to halt the chronic progression of the disease. Lacrimal drainage system could also be involved, usually in a bilateral bicanalicular pattern with severe punctal/canalicular stenosis. Because of severity, the surgical outcomes are not favorable but successive treatments with dacryocystorhinostomy + mitomycin C (MMC), Jones tube implantation, and systemic cyclosporine are reported.Entities:
Keywords: Conjunctivitis; cyclosporine; keratitis; lacrimal drainage system; lichen planus
Year: 2018 PMID: 29985678 DOI: 10.1080/09273948.2018.1485955
Source DB: PubMed Journal: Ocul Immunol Inflamm ISSN: 0927-3948 Impact factor: 3.070